Kwanan nan, sabon littafin mu na gwajin rigakafin cutar coronavirus da tsarin ganowa cikin sauri don rigakafi da sarrafawa ya sami amincewa daga Ofishin Kimiyya da Fasaha na Xiamen.

Littafin gwajin rigakafin cutar coronavirus da sabon tsarin binciken coronavirus da tsarin ganowa yana da bangarori biyu: sabon nau'in kayan aikin rigakafin cutar coronavirus IgM (colloidal zinariya) da kayan aikin ganowa cikin sauri. A cikin novel coronavirus novel coronavirus kamuwa da cuta tsari, IgM antibody shine farkon rigakafi a cikin tsarin rigakafi na ɗan adam. Gano sabon nau'in rigakafi na IgM na coronavirus a cikin matsanancin kamuwa da cuta yana da fa'idodin babban hankali, ganewar asali da kuma ikon tantance ko wanda ake zargi ya kamu da cutar ko a'a. Kit ɗin reagent yana ɗaukar hanyar zinari na colloidal, wanda zai iya karya ta iyakancewar fasahar gano acid nucleic data kasance ga ma'aikata da wurare, da kuma rage lokacin ganowa. A ƙarshe, kamfanin ya haɓaka kayan aikin da ya dace da kayan aikin don tallafawa ganowa, wanda zai iya haɓaka ƙimar ganowa cikin sauri, kuma ma'auni ne mai ƙarfi don tantancewa da kuma kula da yawan jama'ar asymptomatic gabaɗaya a cikin matakin ƙarshe na fashewa.

Novel coronavirus ya mamaye ta yanzu, kuma bala'in da ya haifar da radadin da yake haifarwa ga daukacin al'umma har yanzu yana karuwa. Yana da gaggawa don yaki da annobar. Za ta yi duk abin da kamfanin ya ƙaddamar da samfurin don taimakawa gano layin farko, da kuma ba da gudummawa ga rigakafi da magance cutar.